ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

201 - 220 out of 1,009 results.

SCIESCOPUS
Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations

Ho, A.L.[Ho, A.L.]; Brana, I.[Brana, I.]; Haddad, R.[Haddad, R.]; Bauman, J.[Bauman, J.]; Bible, K.[Bible, K.]; Oosting, S.[Oosting, S.]; Wong, D.J.[Wong, D.J.]; Ahn, M.-J.[Ahn, M.-J.]; Boni, V.[Boni, V.]; Even, C.[Even, C.], et al.

ArticleIssue Date2021CitationJournal of Clinical Oncology, v.39, no.17, pp.1856 - 1864PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) as first-line (1L) treatment for advanced non-small cell lung cancer (NSCLC): 4-year update from CheckMate 227.

Paz-Ares, LG[Paz-Ares, Luis G.]; Ciuleanu, TE[Ciuleanu, Tudor-Eliade]; Lee, JS[Lee, Jong-Seok]; Urban, L[Urban, Laszlo]; Caro, RB[Caro, Reyes Bernabe]; Park, K[Park, Keunchil]; Sakai, H[Sakai, Hiroshi]; Ohe, Y[Ohe, Yuichiro]; Nishio, M[Nishio, Makoto]; Pluzanski, A[Pluzanski, Adam], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Updated overall efficacy and safety of selpercatinib in patients (pts) with RET fusion plus non-small cell lung cancer (NSCLC).

Besse, B[Besse, Benjamin]; Drilon, AE[Drilon, Alexander E.]; Solomon, BJ[Solomon, Benjamin J.]; Subbiah, V[Subbiah, Vivek]; Tan, DSW[Tan, Daniel Shao-Weng]; Park, K[Park, Keunchil]; De Braud, FG[De Braud, Filippo G.]; Alonso, G[Alonso, Guzman]; Wolf, J[Wolf, Juergen]; Soldatenkova, V[Soldatenkova, Victoria], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3).

Go, SI[Go, Se-Il]; Lee, SC[Lee, Sang-Cheol]; Bae, WK[Bae, Woo Kyun]; Zang, DY[Zang, Dae Young]; Lee, HW[Lee, Hyun Woo]; Jang, JS[Jang, Joung Soon]; Ji, JH[Ji, Jun Ho]; Kim, JH[Kim, Jung Hoon]; Park, S[Park, Sanggon]; Sym, SJ[Sym, Sun Jin], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Health-related quality of life for pembrolizumab (pembro) plus ipilimumab (ipi) versus pembro plus placebo in patients with metastatic NSCLC with PD-L1 tumor proportion score >= 50%: KEYNOTE-598.

Sendur, MN[Sendur, Mehmet Nahit]; Reck, M[Reck, Martin]; Rodriguez-Abreu, D[Rodriguez-Abreu, Delvys]; Park, K[Park, Keunchil]; Lee, DH[Lee, Dae Ho]; Cicin, I[Cicin, Irfan]; Yumuk, PF[Yumuk, Perran Fulden]; Orlandi, FJ[Orlandi, Francisco J.]; Leal, TA[Leal, Ticiana A.]; Molinier, O[Molinier, Olivier], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Correlation between work productivity loss (WPL) and European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30) domains from the MONALEESA-7 (ML-7) trial of premenopausal women with HR+/HER2-advanced breast cancer (ABC).

Tripathy, D[Tripathy, Debu]; Curteis, T[Curteis, Tristan]; Hurvitz, SA[Hurvitz, Sara A.]; Yardley, DA[Yardley, Denise A.]; Franke, F[Franke, Fabio]; Kanakasetty, GB[Kanakasetty, Govind Babu]; Wheatley-Price, P[Wheatley-Price, Paul]; Im, YH[Im, Young-Hyuck]; Pencheva, R[Pencheva, Radost]; Chandiwana, D[Chandiwana, David], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Avelumab first-line (1L) maintenance plus best supportive care (BSC) versus BSC alone for advanced urothelial carcinoma (UC): Analysis of time to end of next-line therapy in JAVELIN Bladder 100.

Grivas, P[Grivas, Petros]; Park, SH[Park, Se Hoon]; Voog, E[Voog, Eric]; Kopyltsov, E[Kopyltsov, Evgeny]; Gurney, H[Gurney, Howard]; Muniz, DQB[Muniz, David Queiroz Borges]; Rolland, F[Rolland, Frederic]; Als, AB[Als, Anne Birgitte]; Valderrama, BP[Valderrama, Begona P.]; Wang, J[Wang, Jing], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Measurable residual disease response in acute myeloid leukemia treated with venetoclax and azacitidine.

Pratz, K[Pratz, Keith]; Jonas, BA[Jonas, Brian Andrew]; Pullarkat, V[Pullarkat, Vinod]; Recher, C[Recher, Christian]; Schuh, AC[Schuh, Andre C.]; Thirman, MJ[Thirman, Michael J.]; Garcia, JS[Garcia, Jacqueline Suen]; Dinardo, CD[Dinardo, Courtney Denton]; Vorobyev, V[Vorobyev, Vladimir]; Fracchiolla, N[Fracchiolla, Nicola], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Pembrolizumab (pembro) versus placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase 3 KEYNOTE-240 study.

Finn, RS[Finn, Richard S.]; Edeline, J[Edeline, Julien]; Bouattour, M[Bouattour, Mohamed]; Cheng, AL[Cheng, Ann-Lii]; Chan, SL[Chan, Stephen Lam]; Yau, T[Yau, Thomas]; Garrido, M[Garrido, Marcelo]; Knox, JJ[Knox, Jennifer J.]; Daniele, B[Daniele, Bruno]; Zhu, AX[Zhu, Andrew X.], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.

Krebs, M[Krebs, Matthew]; Johnson, ML[Johnson, Melissa Lynne]; Cho, BC[Cho, Byoung Chul]; Park, K[Park, Keunchil]; Haddish-Berhane, N[Haddish-Berhane, Nahor]; Zemlickis, D[Zemlickis, Donna]; Mitselos, A[Mitselos, Anna]; Meacle, F[Meacle, Francis]; Knoblauch, RE[Knoblauch, Roland Elmar]; Hellemans, P[Hellemans, Peter], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post hoc analysis of the randomized, phase 3 KEYNOTE-240 study.

Zhu, AX[Zhu, Andrew X.]; Cattan, S[Cattan, Stephane]; Merle, P[Merle, Philippe]; Daniele, B[Daniele, Bruno]; Chan, SL[Chan, Stephen Lam]; Yau, T[Yau, Thomas]; Bouattour, M[Bouattour, Mohamed]; Lim, HY[Lim, Ho Yeong]; Chao, Y[Chao, Yee]; Knox, JJ[Knox, Jennifer J.], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Multimodal circulating tumor DNA (ctDNA) colorectal neoplasia detection assay for asymptomatic and early-stage colorectal cancer (CRC).

Lee, J[Lee, Jeeyun]; Kim, HC[Kim, Hee C.]; Kim, ST[Kim, Seung Tae]; He, YP[He, Yupeng]; Sample, P[Sample, Paul]; Nakamura, Y[Nakamura, Yoshiaki]; Raymond, VM[Raymond, Victoria M.]; Jaimovich, A[Jaimovich, Ariel]; Talasaz, A[Talasaz, AmirAli]

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Multicenter study for brain metastasis from breast cancer in Korea: The significance of molecular subtype (Korean Radiation Oncology Group 1612).

Kim, IA[Kim, In Ah]; Kim, JS[Kim, Jae Sik]; Kim, K[Kim, Kyubo]; Jung, W[Jung, Wonguen]; Shin, KH[Shin, Kyung Hwan]; Im, SA[Im, Seock-Ah]; Kim, HJ[Kim, Hee Jun]; Kim, YB[Kim, Yong Bae]; Chang, JS[Chang, Jee Suk]; Kim, JH[Kim, Jee Hyun], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Analysis of clinical and genomic subgroups from the JAVELIN Bladder 100 trial.

Powles, T[Powles, Thomas]; Petrylak, DP[Petrylak, Daniel P.]; Park, SH[Park, Se Hoon]; Sridhar, SS[Sridhar, Srikala S.]; Caserta, C[Caserta, Claudia]; Vuillemin, AT[Vuillemin, Antoine Thiery]; Lee, HJ[Lee, Hyo Jin]; Bellmunt, J[Bellmunt, Joaquim]; Yamamoto, Y[Yamamoto, Yoshiaki]; Aragon-Ching, JB[Aragon-Ching, Jeanny B.], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Isatuximab plus carfilzomib and dexamethasone in east Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis.

Kim, K[Kim, Kihyun]; Min, CK[Min, Chang Ki]; Koh, Y[Koh, Youngil]; Ishizawa, K[Ishizawa, Kenichi]; Kim, SH[Kim, Sung-Hyun]; Ito, S[Ito, Shigeki]; Junji, T[Junji, Tanaka]; Uchiyama, M[Uchiyama, Michihiro]; Kawano, Y[Kawano, Yawara]; Kim, JS[Kim, Jin Seok], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion plus non-small-cell lung cancer (NSCLC).

Drilon, AE[Drilon, Alexander E.]; Gautschi, O[Gautschi, Oliver]; Besse, B[Besse, Benjamin]; Subbiah, V[Subbiah, Vivek]; Tan, DSW[Tan, Daniel Shao-Weng]; Park, K[Park, Keunchil]; De Braud, FG[De Braud, Filippo G.]; Alonso, G[Alonso, Guzman]; Wolf, J[Wolf, Juergen]; Soldatenkova, V[Soldatenkova, Victoria], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with therapy-related myeloid neoplasms, antecedent myelodysplastic syndromes, or myelodysplastic/myeloproliferative neoplasms.

Pullarkat, V[Pullarkat, Vinod]; Pratz, K[Pratz, Keith]; Dohner, H[Dohner, Hartmut]; Recher, C[Recher, Christian]; Thirman, MJ[Thirman, Michael J.]; Dinardo, CD[Dinardo, Courtney Denton]; Fenaux, P[Fenaux, Pierre]; Schuh, AC[Schuh, Andre C.]; Wei, AH[Wei, Andrew H.]; Pigneux, A[Pigneux, Arnaud], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase I dose-escalation and expansion study of JPI-547, a dual inhibitor of PARP/tankyrase in patients with advanced solid tumors.

Im, SA[Im, Seock-Ah]; Lee, S[Lee, SeungHwan]; Lee, KW[Lee, Keun Wook]; Lee, Y[Lee, Youngjoo]; Sohn, J[Sohn, Joohyuk]; Kim, JH[Kim, Jee Hyun]; Im, YH[Im, Young-Hyuck]; Park, KH[Park, Kyong Hwa]; Oh, DY[Oh, Do-Youn]; Kim, MH[Kim, Min Hwan], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Amivantamab in combination with lazertinib for the treatment of osimertinib-relapsed, chemotherapy-naive EGFR mutant (EGFRm) non-small cell lung cancer (NSCLC) and potential biomarkers for response.

Bauml, J[Bauml, Joshua]; Cho, BC[Cho, Byoung Chul]; Park, K[Park, Keunchil]; Lee, KH[Lee, Ki Hyeong]; Cho, EK[Cho, Eun Kyung]; Kim, DW[Kim, Dong-Wan]; Kim, SW[Kim, Sang-We]; Haura, EB[Haura, Eric B.]; Sabari, JK[Sabari, Joshua K.]; Sanborn, RE[Sanborn, Rachel E.], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Long-term quality of life and nutritional results after laparoscopic sentinel node navigation surgery versus laparoscopic standard gastrectomy for early gastric cancer: Secondary outcomes of a multicenter, randomized phase 3 trial (SENORITA).

Eom, BW[Eom, Bang Wool]; Yoon, HM[Yoon, Hong Man]; Kim, YW[Kim, Young-Woo]; Min, JS[Min, Jae Seok]; An, JY[An, Ji Yeong]; Hur, H[Hur, Hoon]; Lee, YJ[Lee, Young-Joon]; Cho, GS[Cho, Gyu Seok]; Park, YK[Park, Young-Kyu]; Jung, MR[Jung, Mi Ran], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
first 11 12 13 14 15 16 17 18 19 20 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어